Articles Referencing NUVA

Zacks.com

HAE Beats on Earnings, Revs in Line - Analyst Blog

Haemonetics Corporation ( HAE ) reported net income of $12.6 million or earnings per share (EPS) of 24 cents in the fourth quarter of fiscal 2013, down 29% and 31% year over... Read >>

Zacks.com

LIFE Beats Earnings, Margins Low - Analyst Blog

Following the announcement of the proposed acquisition deal with Thermo Fisher ( TMO ), Life Technologies Corporation ( LIFE ) reported its first-quarter 2013 earnings per share (EPS)... Read >>

Zacks.com

Symmetry 1Q Earnings Disappoint - Analyst Blog

Symmetry Medical 's ( SMA ) first-quarter 2013 adjusted earnings per share (EPS) of 4 cents missed the Zacks Consensus Estimate of 15 cents. Adjusted earnings exclude one-time items... Read >>

Zacks.com

Hanger 1Q Earnings Beat - Analyst Blog

Hanger Inc. 's ( HGR ) adjusted earnings per share (EPS) of 28 cents for the first quarter of 2013 beat the Zacks Consensus Estimate of 25 cents. It also exceeded the year-ago first quarter... Read >>

Zacks.com

Haemonetics Closes Hemerus Acquisition - Analyst Blog

Recently, Haemonetics ( HAE ) completed the acquisition of Hemerus Medical, a Minn.-based company that develops technologies for the collection of whole blood, and processing and storage of... Read >>

Zacks.com

Earnings Beat at Hospira - Analyst Blog

Hospira Inc. 's ( HSP ) first quarter 2013 adjusted earnings of 52 cents per share beat the Zacks Consensus Estimate of 44 cents. Higher-than-expected revenues led to the earnings beat.... Read >>

Zacks.com

Qiagen Acquires IngenuitySystems - Analyst Blog

In an attempt to manage its growing volume of genomic data, Qiagen ( QGEN ) recently acquired Calif.-based privately owned company, Ingenuity Systems, Inc. Through the acquisition, Qiagen... Read >>

Zacks.com

Reiterate Varian at Neutral - Analyst Blog

On Apr 29, we retained Varian Medical Systems, Inc. ( VAR ) at Neutral after the company reported results for the second quarter fiscal 2013. Why the Reiteration? On April 24, Varian... Read >>

Zacks.com

Covidien's 2Q Earnings Beat - Analyst Blog

Covidien plc. 's ( COV ) adjusted earnings per share (EPS) from continuing operations of $1.12 for the second quarter of fiscal 2013 beat the Zacks Consensus Estimate of $1.10 by 1.8%.... Read >>

Zacks.com

BSX Beats Y/Y Earnings, Guides Low - Analyst Blog

Boston Scientific ( BSX ) reported adjusted earnings per share (after considering certain adjustments other than amortization expense) ("EPS") of 10 cents in the first quarter of... Read >>

Zacks.com

Stryker's 1Q Earnings Beat Est.; Sales Lag - Analyst Blog

Stryker Corporation 's ( SYK ) adjusted earnings per share (EPS) of $1.03 increased 4.0% year over year in the first quarter of 2013. It beat the Zacks Consensus Estimate by 2... Read >>

Zacks.com

Zimmer Beats Earnings, Misses Revenue - Analyst Blog

Zimmer Holdings ( ZMH ) reported adjusted earnings at $1.41, up 8.5% year over year, as well as a penny ahead of the Zacks Consensus Estimate. However, after including one-time items,... Read >>

Zacks.com

Edwards Lags on Earnings & Rev - Analyst Blog

Edwards Lifesciences Corporation's ( EW ) first-quarter 2013 adjusted earnings per share (EPS) came in at 72 cents, up 35.8% year over year, but lagging the Zacks Consensus Estimate of... Read >>

Zacks.com

AmSurg's Rev and Earnings In Line - Analyst Blog

AmSurg Corp. 's ( AMSG ) first-quarter 2013 adjusted earnings per share ("EPS") of 52 cents were 2 cents ahead of the year-ago quarter EPS and in line with the Zacks Consensus... Read >>

Zacks.com

Abbott - Epizyme Collaborate - Analyst Blog

Abbott Laboratories ( ABT ) recently announced a strategic deal with Epizyme, Inc. for the development of a molecular companion diagnostic test for use with EPZ-5676. EPZ-5676 is being... Read >>

Displaying 1-15 of 78
<< first < previous 1 2 3 4 5 6 next > last >>